Serum to launch herbal therapy for BPH
Serum Institute of India Ltd is launching a phyto-therapeutic agent, Pyginal, for the treatment of benign prostate hyperplasia this week, it is reliably learnt.

Hepatitis B vaccine segment annually degrowing at 46 per cent
The Rs 83-crore hepatitis B vaccine segment in India is degrowing at the rate of 46 per cent, according to annual wholesale market research figures for January-December 2002.

At A Glance